Priority Date: 14.06.16 (US 201662350095P)

EXPRESSION OF NKG2D ACTIVATING LIGAND PROTEINS FOR SENSITIZING CANCER CELLS TO ATTACK BY CYTOTOXIC IMMUNE CELLS

  • Application ID: EP17814031
  • Status: Request for examination was made

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 174 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2016 - Priority Date (US 201662350095P)
  • 21.12.2017 - Publication A1 (WO2017218689)
  • 17.04.2019 - Publication A1 (EP3468588)

IPC Classification